Your browser doesn't support javascript.
loading
Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
Augustin, Matthias; Costanzo, Antonio; Pink, Andrew; Seneschal, Julien; Schuster, Christopher; Mert, Can; Guerreiro, Mariana; Tietz, Nicole; Grond, Susanne; De Bruin-Weller, Marjolein.
Afiliación
  • Augustin M; University Medical Center, Hamburg-Eppendorf, Germany. m.augustin@uke.de.
  • Costanzo A; Humanitas University Medical School Dermatology Via Alessandro Manzoni, Rozzano, Italy.
  • Pink A; St. John's Institute of Dermatology, Guy's & St. Thomas' Hospitals, London, UK.
  • Seneschal J; Department of Dermatology, National Reference Center for Rare Skin Disorders, University of Bordeaux, Bordeaux, France.
  • Schuster C; Eli Lilly and Company, Indianapolis, IN, USA.
  • Mert C; HaaPACS GmbH, Schriesheim, Germany.
  • Guerreiro M; Eli Lilly and Company, Indianapolis, IN, USA.
  • Tietz N; Eli Lilly and Company, Indianapolis, IN, USA.
  • Grond S; Eli Lilly and Company, Indianapolis, IN, USA.
  • De Bruin-Weller M; National Expertise Center of Atopic Dermatitis, Deptartment of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands.
Acta Derm Venereol ; 102: adv00830, 2022 Dec 07.
Article en En | MEDLINE | ID: mdl-36479885
Atopic dermatitis is a chronic inflammatory skin disorder associated with a heterogeneous presentation and considerable disease burden. Exploring atopic dermatitis treatment patterns and patient benefits could improve disease management and patients' quality of life. This study aimed to describe current and previous atopic dermatitis treatment patterns and patient benefits from those treatments to inform disease management. Data were collected in 10 countries. Adults (n = 1,988) with confirmed moderate-to-severe atopic dermatitis completed a web-based cross-sectional survey. Most patients (86.6%) had body surface area involvement <10%, and therapies used were topical (69.7%), systemic (28.1%), and biologics (2.3%). Most flares were managed by topical monotherapies (73.4%), even in patients with body surface area involvement ≥10%. Treatment expectations were met only partially, or not at all, in 75% of patients. Those with body surface area involvement ≥10% reported lower treatment satisfaction. Overall, this study highlights the unmet medical needs in atopic dermatitis management.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Satisfacción del Paciente / Dermatitis Atópica Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Acta Derm Venereol Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Satisfacción del Paciente / Dermatitis Atópica Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Acta Derm Venereol Año: 2022 Tipo del documento: Article País de afiliación: Alemania
...